Grants per year
Prot #PR-30-5020-C: A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Patients with Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least
Nieves-Neira, W. & Pineda, M. J.
5/20/15 → 8/31/20
Project: Research project